ABSI
NASDAQ · Biotechnology
Absci Corp
$8.93
+0.63 (+7.59%)
Open$8.55
Previous Close$8.30
Day High$8.97
Day Low$8.47
52W High$12.06
52W Low$2.24
Volume—
Avg Volume2.53M
Market Cap1.51B
P/E Ratio—
EPS$-0.83
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+163.7% upside
Current
$8.93
$8.93
Target
$23.55
$23.55
$16.79
$23.55 avg
$35.63
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.58M | 4.55M | 58.57M |
| Net Income | -147,099,603 | -168,284,787 | -8,944,093 |
| Profit Margin | -4,113.7% | -3,908.0% | -15.3% |
| EBITDA | -138,662,468 | -167,445,461 | -15,160,350 |
| Free Cash Flow | — | — | -10,726,027 |
| Rev Growth | -21.3% | -21.3% | +10.3% |
| Debt/Equity | 0.00 | 0.00 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |